Work

Additional file 3 of Symptomatic progression-free survival as an emerging patient-centered endpoint in multiple myeloma: a secondary analysis of MagnetsiMM-3 trial data

Year: 2025

Type: article

Abstract: Supplementary Material 3

Source: Figshare

DOI: 10.6084/m9.figshare.29874525

Authors: Kortüm, Martin, Theurich, Sebastian, Farrell, James, Jackson, Graham, Cook, Gordon, Cappelleri, Joseph C., Ashman, Olivia, Neff-Baro, Shanti, Gauthier, Aline, Jewiti-Rigondza, Khalil, Sidhom, Alaeddine, Chaudhary, Ashraf, Scheid, Christof

Institutions: University of Würzburg, LMU Klinikum, Ludwig-Maximilians-Universität München, Pfizer (Ireland), Freeman Hospital, University of Leeds, Pfizer (United States), Pfizer (United Kingdom), University Hospital Cologne

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6902299030

FWCI:

Cites:

Cited by:

Related to: